After a $5 million raise, WA gold explorer Arika has tongues wagging with the vote of confidence from A-list investors like John Forwood.

Adisyn has taken an early step toward solving one of the semis industry’s toughest problems, and this could be a development worth watching.

With an expanded product portfolio, Avita Medical is on a concerted US push to win market share and become profitable by the end of the year ...

Many Peaks Minerals has received broad high-grade results from Ouarigue South prospect of the Ferké gold project in Côte ...

The RBA has cut rates as expected, delighting investors who piled into growth stocks in Info Tech and Finance sectors.

ASX climbs 0.75pc out of the gate as markets bet on even chance of 50-bp interest rate cut from the RBA's rate decision today ...

A sharp rise in uranium spot prices off recent lows has seen analysts grow more bullish that market sentiment is turning in ...

Initial results, pending column leach test validation, suggest the ability to optimise leach outcomes by adjusting acid ...

A ruling by the Australian ­Financial Complaints Authority has illuminated hazards of being unaware of fine print in life insurance policies.

As another Bitcoin Pizza Day approaches, more and more investors are giving the digital asset a fresh out-of-the-oven look.

Investors now have three ASX-listed stem cell therapy companies to choose from – and we can thank Mesoblast for inspiring the third.

The ASX has bounced back amid rate-cut hopes. Meanwhile Wall Street gained and China had investors wading back into banks and tech plays.